LIAU LINDA M.
Known title: DirectorCIK: 0001890712
Associated companies
Transaction History
| CLPT | ▲ Buy | Option Exercise | 12,417 | — | 5/19/2026 | View on chart |
| CLPT | ▲ Buy | Option Exercise | 21,093 | — | 5/16/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 193 | $3K | 1/2/2025 | View on chart |
| CLPT | ▲ Buy | Grant | 264 | $3K | 10/1/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 550 | $3K | 7/1/2024 | View on chart |
| CLPT | ▲ Buy | Option Exercise | 17,153 | — | 5/14/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 436 | $3K | 4/1/2024 | View on chart |
| CLPT | ▲ Buy | Grant | 9,269 | $0 | 5/25/2022 | View on chart |
| CLPT | ▲ Buy | Grant | 3,426 | $0 | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
CLPT Featured in Pre-Market Movers
ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.
CLPT Featured in Pre-Market Movers. ClearPoint Neuro (CLPT) was highlighted in pre-market lists for Tuesday, indicating notable trading activity before the open. The stock is currently trading near its 52-week low of $8.27 and has shown a volume spike. While analyst targets remain significantly higher at an average of $23.50, the recent price action suggests heightened volatility and interest from traders.